The global mixed mode chromatography resin market size was valued at USD 75.4 million in 2017 and is anticipated to expand at a revenue-based CAGR of 7.1% over the forecast period on account of increase in healthcare expenditure all around the world, coupled with rising use of mixed mode resin for therapeutic drug treatment. Rise in number of contract manufacturing organizations (CMOs) and contract research organizations (CROs) is also expected to drive the market from 2017 to 2025.
Demand in the market has been on a rise thanks to ongoing developments in drug discovery processes by leading pharmaceutical companies, particularly to find a cure for widespread diseases such as Ebola, Zika, and H1N1. Big and established pharma and biopharma companies now outsource most biopharmaceutical drug discovery and development activities.
Chromatography helps companies develop and manufacture biological pharmaceutical tools to achieve safety and quality. Currently, chromatography is applied as a valued technique for purification, separation, and analysis of compounds present in complex mixtures and used in pharmaceutical, chemical, biochemistry, and environmental science.
High cost of raw material, coupled with need for highly skilled workforce to perform these techniques has resulted in increasing the overall cost of chromatography. This high cost compared to other separation techniques is expected to act as a restraint for the market over the forecast period.
The market is segmented by technique into ion exchange - hydrophobic and hydroxyapatite. Ion exchange - hydrophobic resin emerged as the dominant segment in the mixed mode chromatography resin market in 2017 owing to rapid growth in drug discovery activities in developed as well as developing economies. The segment is also expected to grow at the fastest CAGR during the forecast period in terms of both revenue and volume.
The use of chromatography in the pharmaceutical sector as per the U.S. FDA regulations is witnessing growth, which is favorably influencing the market. The European Medical Agency’s (EMA) initiative to ensure drug safety is likely to trigger the growth of the global market.
Increasing demand for therapeutic antibodies for treatment of patients is also a major driver that is triggering industry growth. The trend of replacing conventional separation techniques such as filtration and distillation with chromatography has also driven innovation for the application of chromatography in various new segments.
North America is expected to remain a key region in the global market, driven primarily by U.S. The country has been enjoying robust growth due to strong government spending in research and development activities.
Demand in Asia Pacific is expected to grow at an exponential rate. This development can be credited to many initiatives by Chinese and Indian governments to boost their biotechnology and pharmaceutical sectors. Asia Pacific is anticipated to continue as the fastest growing regional market during the forecast period.
High healthcare expenditure, increasing disposable in emerging economies, and high availability of cheap and skilled workforce is expected to boost the biotechnology sector in emerging economies of Asia Pacific, which will in turn propel the overall market.
GE Healthcare Lifesciences, Merck KGaA, Tosoh Corp, Purolite Corp, Danaher Corp, and Bio-Rad Labs are some of the major market players. In November 2015, Sigma-Aldrich was acquired by Merck KGaA and this allowed Merck to foray into the chromatography market. Extensive R&D in the global resin industry has driven the development of novel resin products that have better productivity compared to conventional resins.
|
Attribute |
Details |
|
Base year for estimation |
2017 |
|
Actual /Historical data |
2014 - 2016 |
|
Forecast period |
2018 - 2025 |
|
Market representation |
Volume in Thousand Liters; Revenue in USD Million, and CAGR from 2018 to 2025 |
|
Regional scope |
North America, Europe, Asia Pacific |
|
Country scope |
U.S., U.K., Germany, France, China, India, Japan, South Korea. |
|
Report coverage |
Revenue forecast, competitive landscape, growth factors and trends |
|
15% free customization scope (equivalent to 5 analysts working days) |
If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis on latest industry trends and opportunities in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global mixed mode chromatography resin market report on the basis of technique, end use, and region:
Technique Outlook (Volume, Thousand Liters; Revenue, USD Million, 2014 - 2025)
Ion exchange - Hydrophobic
Hydroxyapatite
Others
End-use Outlook (Volume, Thousand Liters; Revenue, USD Million, 2014 - 2025)
Pharmaceutical and Biotechnology
Regional Outlook (Volume, Thousand Liters; Revenue, USD Million, 2014 - 2025)
North America
U.S.
Europe
U.K.
Germany
France
Asia Pacific
China
India
Japan
South Korea
Avail customized purchase options to meet your exact research needs:
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."
